For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...
Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...
Obesity can put strain on the heart, resulting in an increased risk of conditions such as atrial fibrillation, or irregular ...
Atrial fibrillation (AF) is the most common abnormal heart rhythm affecting 6 million people in the USA and can cause strokes and heart failure. Conventional treatments are successful but may need to ...
Cardiovascular management strategies are essential to individuals with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) undergoing active treatment, due to the high rate of atrial ...
Researchers from Mass General Brigham evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the ...
That test could help identify patients at greatest risk for potentially deadly cardiac problems such as coronary artery disease, atrial fibrillation (irregular heartbeat) and heart failure, and ...
Baseline characteristics and antiarrhythmic drugs used were similar in ... AF burden by 25% (2.50% control vs. 1.87% treatment). Atrial fibrillation burden decreased progressively in both groups ...
New research shows how alcohol affects heart health in women on hormone therapy. Find out the shocking connection and what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback